Stock Track | Cellebrite Stock Soars 13.65% After Hours on Strong Q3 Results and Positive Outlook

Stock Track
11/13

Cellebrite (CLBT) shares surged 13.65% in after-hours trading on Wednesday following the release of its third-quarter 2025 financial results, which exceeded analyst expectations and showcased robust growth across key business segments.

The digital investigative solutions provider reported Q3 revenue of $126.03 million, beating the consensus estimate of $122.01 million and representing an 18% year-over-year increase. Adjusted EBITDA also outperformed, coming in at $37.74 million compared to the expected $32.18 million, reflecting a strong operational performance with a 29.9% adjusted EBITDA margin.

Cellebrite's CEO, Thomas E. Hogan, highlighted the company's balanced and solid performance, noting significant expansion within the U.S. Federal business segment. "We exceeded the high end of our prior adjusted EBITDA guidance with revenue at the high end of expectations," Hogan stated. The company's execution demonstrated resilience and the growing importance of its solutions to global public safety initiatives.

Key drivers of the quarter's success included a 21% growth in subscription revenue, fueled by strong demand in U.S. state and local markets, as well as in Latin America. The company also announced its Autumn 2025 Release, introducing new capabilities and integrations that enhance its Digital Investigation Platform, further solidifying its market position.

Looking ahead, Cellebrite provided an optimistic outlook for the remainder of 2025 and beyond. The company expects full-year 2025 revenue between $470 million and $475 million, representing a 17% to 18% annual growth. Additionally, Cellebrite anticipates Q4 2025 adjusted EBITDA in the range of $35 million to $38 million, signaling continued strong performance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10